Biotechnology
OpenAI’s GPT-Rosalind is a large language model tuned on common biology workflows and public databases, built to suggest pathways and prioritise drug targets. Citing bioweapon risk, OpenAI is limiting access to vetted US-based researchers for now.
WHY THIS MATTERS IN BRIEF Life runs on ATP – the energy molecules of all living things – and now we can convert electricity into…
WHY THIS MATTERS IN BRIEF What’s the worst that could happen if you could trick a researcher into fabricating a new bioweapon? Love the…
WHY THIS MATTERS IN BRIEF Once oil wells are tapped out they’re capped, but now they’re getting a new lease of life after bacteria injected…
WHY THIS MATTERS IN BRIEF This is the second time we’ve created a superbug, and it shows how powerful gene editing technology can be. …
WHY THIS MATTERS IN BRIEF Life’s DNA has always been coded using just four letters, but now researchers have added two new letters and it…
WHY THIS MATTERS IN BRIEF This could cause a conundrum – is lab made meat considered vegan? From an environmental and humanitarian point of…
WHY THIS MATTERS IN BRIEF Noone will be sad to see the back of animal testing. Before a new drug or medical treatment can…
